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mals, 17  -estradiol benzoate (EB) treatment increased SRC-1 
levels in the arcuate nucleus, but not the medial preoptic 
area or the ventromedial nucleus of the hypothalamus. EB 
did not alter SRC-2 expression in any of the three brain re-
gions analyzed.  Conclusions: Taken together, the present 
findings identify a population of cells in which steroid recep-
tors and nuclear receptor coactivators may interact to mod-
ulate steroid sensitivity in brain and regulate hormone-de-
pendent behaviors in female mice. Given that cell culture 
studies reveal that SRC-1 and SRC-2 can mediate distinct ste-
roid-signaling pathways, the present findings suggest that 
steroids can produce a variety of complex responses in these 
specialized brain cells.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 The ovarian hormones estradiol (E) and progesterone 
regulate growth, proliferation and differentiation in a va-
riety of tissues. In addition, these hormones play an im-
portant role in hormone-dependent cancers of the repro-
ductive systems, including breast cancer  [1] . E and pro-
gesterone act in specific brain regions to influence a 
variety of functions, including cognition and female re-
productive behavior and physiology  [2, 3] . 
 Estrogens and progestins bind to their respective ste-
roid receptors, ER and PR, which are members of a su-
perfamily of ligand-dependent transcription factors. In-
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 Abstract 
 Background/Aims: The steroid hormones, including estra-
diol (E) and progesterone, act in the brain to regulate female 
reproductive behavior and physiology. These hormones me-
diate many of their biological effects by binding to their re-
spective intracellular receptors. The receptors for estrogens 
(ER) and progestins (PR) interact with nuclear receptor co-
activators to initiate transcription of steroid-responsive 
genes. Work from our laboratory and others reveals that nu-
clear receptor coactivators, including steroid receptor coac-
tivator-1 (SRC-1) and SRC-2, function in brain to modulate
ER-mediated induction of the PR gene and hormone-de-
pendent behaviors. In order for steroid receptors and co-
activators to function together, both must be expressed in 
the same cells.  Methods: Triple-label immunofluorescence 
was used to determine if E-induced PR cells also express SRC-
1 or SRC-2 in reproductively relevant brain regions of the fe-
male mouse.  Results: The majority of E-induced PR cells in 
the medial preoptic area (61%), ventromedial nucleus of the 
hypothalamus (63%) and arcuate nucleus (76%) coexpressed 
both SRC-1 and SRC-2. A smaller proportion of PR cells ex-
pressed either SRC-1 or SRC-2, while a few PR cells expressed 
neither coactivator. In addition, compared to control ani-
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tracellular ER exist as two subtypes,   and   , which are 
transcribed from different genes  [4–6] . In primates and 
rodents, PR are expressed in two forms; the full-length 
PR-B and the N-terminal truncated PR-A, which are en-
coded by the same gene but are regulated by different 
promoters  [7] . In the traditional genomic mechanism of 
action, these steroid receptors bind hormones and un-
dergo a conformational change that causes the dissocia-
tion of heat shock proteins and other immunophilins  [8] . 
Activated receptors dimerize and bind preferentially to 
specific hormone response elements in the promoter re-
gions of target genes to increase or decrease gene tran-
scription  [9, 10] . In addition, ER and PR have been found 
to function in the absence of ligand and at the membrane 
to rapidly activate cytoplasmic signaling pathways  [11–
15] .
 A classic example of a steroid-induced gene is the in-
duction of the PR gene by E in a variety of tissues, includ-
ing brain. This ER-mediated induction of PR is thought 
to occur via an estrogen response element in the promot-
er region of the PR gene  [16–18] . While PR are present in 
low levels in the brains of ovariectomized rodents, E 
priming dramatically increases the expression of PR in 
the medial preoptic area (MPA), arcuate nucleus (ARC) 
and ventromedial nucleus of the hypothalamus (VMN) 
 [19–28] . Based on studies in ER knockout mice, E induc-
tion of PR in brain appears to be predominantly, while 
not solely  [29] , dependent on ER   [30–32] . In support of 
this ER  -mediated event, virtually all E-induced PR cells 
in the hypothalamus also express ER   [26, 33] . These E-
induced PR in the hypothalamus are important for pro-
gesterone-facilitated reproductive behavior  [34] . In addi-
tion, studies using PR-A- and PR-B-specific knockouts 
reveal that while both receptors are important, PR-A ap-
pears to have a larger role in the full display of progester-
one-facilitated lordosis  [35] .
 Nuclear receptor coregulators consist of coactivators 
and corepressors that are required for efficient transcrip-
tional regulation by nuclear receptors  [36–39] . There is 
mounting evidence that coregulators are involved in hu-
man disease, including metabolic disorders and cancers 
 [40] . Nuclear receptor coactivators dramatically enhance 
the transcriptional activity of nuclear receptors, includ-
ing PR and ER, through a variety of mechanisms, includ-
ing acetylation, methylation, phosphorylation and chro-
matin remodeling  [36, 37] . In vitro, these coactivators are 
often rate limiting for steroid receptor activation and act 
as bridging proteins between the receptor and the basal 
transcriptional machinery  [36, 37] . 
 The p160 steroid receptor coactivator (SRC) family in-
cludes SRC-1/NcoA-1  [41] , SRC-2/TIF2/GRIP1/NcoA2 
 [42, 43] , and SRC-3/p/CIP/ACTR/AIB1/TRAM-1/RAC3 
 [44, 45] . Recent work reveals that two members of this 
p160 family of coactivators, SRC-1 and SRC-2, are impor-
tant for hormone action in brain and behavior  [46, 47] . 
SRC-1  [48–57] and SRC-2  [58–60] are expressed at high 
levels in the cortex, hypothalamus and hippocampus of 
rodents. Our laboratory and others have found that SRC-
1 and SRC-2 are important for hormone-dependent sex-
ual differentiation of the brain  [53] , gene expression in 
brain  [54, 61–63] and sexual behavior  [54, 61–64] . Final-
ly, SRC-1 and SRC-2 from rodent brain physically interact 
with ER and PR in a receptor subtype- and brain region-
specific manner  [58, 65] .
 In order for coactivators to function with steroid re-
ceptors in hormone action in brain, both the coactivators 
and receptors must be expressed in the same cells. Our 
previous work in female rats reveals that the majority of 
E-induced PR cells in the hypothalamus also express 
SRC-1  [48] . In support, SRC-1 and SRC-2 expression is 
significantly related to PR expression in hormone-re-
sponsive meningiomas  [66] . In contrast, SRC-1 was not 
detected in mouse mammary epithelial cells expressing 
E-induced PR  [67] , suggesting that SRC-1 functions in a 
cell-type- and tissue-specific manner. However, it is not 
known if SRC-1 or SRC-2 are expressed in PR-containing 
cells in mouse brain. Therefore, we used a triple-label im-
munofluorescent technique to ask if E-induced PR cells 
expressed SRC-1, SRC-2 or both coactivators in repro-
ductively relevant brain regions of female mice. 
 Materials and Methods 
 Animals 
 Female C57 mice, 5–6 weeks old, were obtained from Taconic 
(Germantown, N.Y., USA) and group-housed for 1 week under a 
12: 12-hour light/dark cycle with food and water freely available. 
One week after arrival, the animals were ovariectomized under 
1.5% isoflurane. One week following ovariectomy, the mice were 
injected subcutaneously with either 17  -estradiol benzoate (EB, 
1   g in sesame oil) or vehicle 48 h prior to sacrifice. Ovariecto-
mized mice treated with EB (n = 8) or vehicle (n = 7) were anes-
thetized with Fatal Plus (sodium pentobarbital 0.1 ml, 390 mg/ml) 
and perfused with 4% paraformaldehyde. Five thousand units of 
sodium heparin dissolved in saline were injected into the left ven-
tricle. Saline (0.15  M , 8 ml) preceded the flow of 4% paraformal-
dehyde in 0.1  M sodium phosphate buffer (pH = 7.2) at a flow rate 
of 8 ml/min for 8 min. Brains were removed from the cranium, 
blocked and stored in 0.1  M sodium phosphate buffer (pH = 7.2) 
containing 20% sucrose at 4  °  C for 48 h. Coronal sections were cut 
on a freezing rotary microtome at 40   m from the MPA through 
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the hypothalamus following the mouse brain atlas  [68] . The sec-
tions were stored in cryoprotectant at –20  °  C until processing. All 
animal procedures were approved by the Institutional Animal 
Care and Use Committees of Wellesley College.
 Immunohistochemistry 
 A triple-label immunohistochemistry technique was used to 
identify cells expressing PR, SRC-1 and SRC-2 in the VMN, ARC 
and MPA. The brain sections were incubated in 0.05  M Tris-buff-
ered saline (TBS) and incubated in donkey anti-mouse IgG to oc-
cupy the endogenous mouse antibodies. The sections were washed 
again in TBS and incubated in 20% donkey serum to reduce non-
specific binding. To detect PR, SRC-1 and SRC-2, the sections 
were incubated for 24 h at 4  °  C in a cocktail containing a PR mouse 
monoclonal antibody directed against amino acids 922–933 of the 
C-terminus of human PR (1: 6,000, MAB 462, Millipore), an SRC-
1 goat polyclonal antibody directed against the C-terminus (aa 
1355–1405) mouse SRC-1 (1: 250, M-20, sc-6098, Santa Cruz Bio-
technology), and an SRC-2 rabbit polyclonal antibody directed 
against the C-terminus (aa 1400–1464) of human SRC-2 (1: 1,000, 
NB100-1756, Novus Biologicals). The specificities of the PR and 
SRC-1 antibodies have been established previously in rodent 
brain  [48, 69, 70] . Analysis of homogenates of mouse hypothala-
mus by Western blot using NB100-1756 revealed a distinct immu-
noreactive band for SRC-2 (see online supplementary figure 1, 
www.karger.com/doi/10.1159/000323780) at the expected molec-
ular mass of 160 kDa  [41, 42] . The sections were washed with TBS 
and incubated in a cocktail of fluorescently labeled secondary an-
tisera containing donkey anti-mouse serum (1: 300, Alexa 594, In-
vitrogen) for detection of PR, donkey anti-goat (1: 100, Alexa 488) 
for detection of SRC-1, and donkey anti-rabbit (1: 100, Alexa 647) 
for detection of SRC-2. The sections were then washed with TBS 
and mounted on gel-coated glass slides, coverslipped with Fluoro-
Gel (EMS) and stored at 4  °  C. 
 Controls for this triple-label technique included the omission 
of the primary or secondary antibodies. In addition, primary an-
tibodies were preadsorbed with 20-fold molar excess of SRC-1 
peptide of the C-terminus (SRC-1 M-20 P, Santa Cruz Biotechnol-
ogy), a fragment of GST-tagged recombinant human SRC-2 pro-
tein consisting of aa 1365–1465 (H00010499-Q01, Novus Biolog-
icals) or full-length human PR-B protein. Recombinant human 
PR-B proteins were expressed in  Spodoptera frugiperda (Sf9) in-
sect cells from the Baculovirus/Monoclonal Antibody Facility at 
the Baylor College of Medicine, as described previously  [71, 72] .
 Imaging by Confocal Microscopy and Analysis 
 The MPA (fig.  33 of  [68] ), VMN (fig.  46 of  [68] ) and ARC 
(fig. 46 of  [68] ), which are rich in E-induced PR, were analyzed 
with the experimenter blind to treatment groups. Images of im-
munofluorescence from one section per brain region were cap-
tured at 200 ! with a Leica TCS SP laser scanning confocal mi-
croscope (equipped with an argon laser 488, diode laser 561 and 
helium-neon laser 633) using imaging software (LCS 1347a, Lei-
ca). For each brain region, a two-dimensional 1-  m optical sec-
tion (512  ! 512) was captured and analyzed. One side of a repre-
sentative section of each animal was analyzed using a uniform 
region of interest for the MPA (total area of the region of inter-
est = 44,981   m 2 ), VMN (total area = 40,373   m 2 ) and ARC (total 
area = 59,809   m 2 ). For each brain region, the region of interest 
was placed over the highest concentration of PR-immunoreactive 
(IR) cells in EB-treated animals and the corresponding area for 
vehicle animals. Laser output (mV) was measured using a Field-
Master (Coherent) and kept constant between animals and imag-
ing sessions. Triple-labeled images (8-bit) were analyzed using 
NIS Elements (Nikon). The threshold for detection of specific im-
munoreactivity was determined as a function of background. For 
each brain region, the threshold was established as the mean max-
imum pixel intensity (ranging from 0 to 256) of 10 random sam-
ples of background for 3 randomly selected animals in each group. 
Within each optical section, cells were considered immunoposi-
tive if above the threshold value and the total area was greater than 
8.0   m 2 . To insure unbiased data collection for each optical sec-
tion of a brain region, all objects that met the established criteria 
were counted in a uniform region of interest. In each brain region, 
the number of immunoreactive cells and the average optical den-
sity were collected for PR immunoreactivity, SRC-1 immunoreac-
tivity and SRC-2 immunoreactivity. 
 Statistical Analysis 
 To determine if EB influenced the expression of SRC-1 or
SRC-2, images of matched sections from EB-treated and control 
animals were analyzed for total cell counts and relative optical 
density for coactivator immunoreactivity using NIS Elements 
(Nikon). Because the data were not normally distributed, differ-
ences in coactivator immunoreactivity between the EB and con-
trol groups were compared using a Kruskal-Wallis one-way anal-
ysis of variance by rank test (Statistica). Differences were consid-
ered statistically significant at a probability  ! 0.05. 
 Results 
 Coexpression of E-Induced PR, SRC-1 and SRC-2 
 Consistent with previous studies in mice and rats, 
many E-induced PR-IR cells were detected in EB-treated 
mice, while little to no PR were observed in control ani-
mals  [20, 21, 23, 25, 30, 31, 34, 73–78] in the VMN (EB = 
35.0  8 2.0 cells vs. oil = 0.3  8 0.2; p  ! 0.001), ARC (109.3 
 8 23.7 vs. 1.6  8 1.4; p  ! 0.01) and MPA (139.0  8 25.9 vs. 
31.1  8 17.1; p  ! 0.01) ( fig. 1 a, b,  2 a). Similar differences in 
the average optical density of PR immunoreactivity were 
found between EB and control animals (data not shown). 
 SRC1-IR cells were observed throughout the hippo-
campus, amygdala (data not shown) and hypothalamus, 
including the VMN, ARC and MPA ( fig. 1 b, f,  2 b), which 
is consistent with other limited studies of SRC-1 mRNA 
in mice  [59, 79] . In addition, the present findings of SRC-
1 expression in mouse brain are consistent with previous 
studies in rats  [48–54, 70, 80] and birds  [57, 81] . SRC2-IR 
cells were detected throughout the mouse hippocampus, 
amygdala (data not shown) and hypothalamus, including 
the VMN, ARC and MPA ( fig. 1 c, g,  2 c). While the pat-
tern of SRC-2 expression in brain has been studied much 
less, these results are consistent with other findings in 
mice and rats  [59–61] . 
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 We found that a large majority of cells containing E-
induced PR in the VMN coexpressed both SRC-1 and 
SRC-2 ( table 1 ;  fig. 1 d). In addition, most of the E-induced 
PR cells in the MPA and ARC coexpressed both SRC-1 
and SRC-2 ( table 1 ;  fig. 2 d). A smaller proportion of E-
induced PR cells in these three brain regions contained 
only SRC-1. Interestingly, in all three brain regions, fewer 
PR cells expressed SRC-2 only than SRC-1 only ( table 1 ). 
A relatively small population of E-induced PR-IR cells ex-
pressed neither of the coactivators. In the VMN, the ma-
jority of coactivator-expressing cells also expressed PR 
( table 1;  fig. 1 d). However, in contrast to the VMN, the 
majority of SRC1-IR and SRC2-IR cells in the ARC and 
MPA did not express E-induced PR ( table 1 ). 
a b c d
e f g h
PR SRC-1 SRC-2 Overlay
Table 1.  Cells immunostained for PR, SRC-1 and SRC-2 in the mouse VMN, ARC and MPA
Brain 
region










SRC-1 only SRC-2 only SRC-1 and SRC-2
VMN 3582.0 3986 3387 12 18 7 63 78 82
ARC 109822 232815 195825 3 18 2 76 44 45
MPA 139824 250829 235834 7 19 13 61 44 44
T otal numbers of cells per region of interest for each brain region are shown as the mean 8 SEM.
 Fig. 1. E-induced PR cells coexpress SRC-1 and SRC-2 in the VMN 
of female mice. The VMN of animals treated with EB ( a–d ) or ve-
hicle ( e–h ) were immunostained for PR ( a ,  e ), SRC-1 ( b ,  f ), or SRC-
2 ( c ,  g ).  d ,  h Overlaid image shows cells expressing PR, SRC-1 and 
SRC-2 (yellow circles), shown in inset at higher magnification. 
Red circles indicate a cell expressing PR only, green circles indi-
cate a cell expressing SRC-1 only and blue circles indicate a cell 
expressing SRC-2 only. Bar = 50   m.  
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 Regulation of Nuclear Receptor Coactivator 
Expression by Estradiol 
 To determine if EB alters the expression of SRC-1 or 
SRC-2 expression in the VMN, MPA or ARC, sections 
from EB- and vehicle-treated animals were compared. EB 
increased the number of SRC1-IR cells in the ARC, but 
not in the MPA or VMN ( fig. 2 b, f,  3 a). No differences 
were detected in the number of SRC2-IR cells between EB 
and control animals in the three brain regions analyzed 
( fig. 3 b). Similar effects were detected in the relative opti-
cal densities of SRC-1 and SRC-2 immunoreactivity be-
tween EB- and vehicle-treated animals (data not shown). 
 Controls for Triple-Label Immunohistochemistry 
 Controls were performed to confirm specificity of the 
triple-label immunohistochemistry technique. Omission 
of each individual primary antibody resulted in no de-
tectable immunoreactivity of the respective label (data 
not shown). In addition, omission of each individual sec-
ondary antibody resulted in no observable immunoreac-
tivity of the respective label (data not shown). Preadsorp-
tion of (1) MAB-462 with a 20-fold excess of recombinant 
human PR-B protein resulted in no PR immunoreactivi-
ty, (2) M-20 with a 20-fold molar excess of SRC-1 peptide 
of the C-terminus resulted in no SRC-1 immunoreactiv-
a b c d
e f g h
PR SRC-1 SRC-2 Overlay
 Fig. 2. Expression of PR, SRC-1 and SRC-2 in the ARC of female 
mice treated with EB or vehicle. The ARC of animals treated with 
EB ( a–d ) or vehicle ( e–h ) were immunostained for PR ( a ,  e ), SRC-
1 ( b ,  f ), or SRC-2 ( c ,  g ). Red circles indicate a cell expressing PR 
only and yellow circles indicate a cell expressing PR, SRC-1 and 










































 Fig. 3. EB regulates SRC-1 expression in 
the ARC. Average number ( 8 SEM) of cells 
immunoreactive for SRC-1 ( a ) or SRC-2 
( b ) per region of interest for the VMN, 
ARC and MPA from oil- (open bars) and 
EB- (grey bars) treated mice.  *  p  ! 0.02.  
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ity, and (3) NB100-1756 (SRC-2) with a fragment of re-
combinant human SRC-2 protein resulted in no SRC-
2 immunoreactivity (data not shown). In further confir-
mation of the specificity of the triple-label technique, 
intensely labeled cells with only PR, SRC-1 or SRC-2 im-
munoreactivity were observed. 
 Discussion 
 Our laboratory and others have shown that the nucle-
ar receptor coactivators SRC-1 and SRC-2 are important 
for steroid action in the brain. These coactivators modu-
late ER-mediated transactivation of the PR gene in the 
brain and ER- and PR-dependent reproductive behaviors 
in female rodents  [54, 61, 64] . In order for nuclear recep-
tor coactivators to function with steroid receptors in 
brain, both coactivator and receptor must be expressed in 
the same cell. In the present study, triple-label immuno-
fluorescence was used to investigate the coexpression of 
E-induced PR with SRC-1 or SRC-2 in individual cells in 
the female mouse brain.
 SRC-1 and SRC-2 were expressed at high levels in the 
VMN, ARC and MPA, regions known to be involved in 
reproductive behavior. Interestingly, the majority of E-
induced PR cells in the VMN, MPA and ARC coexpress 
both SRC-1 and SRC-2. Given that virtually all E-induced 
PR cells in the hypothalamus express ER   [26, 33] , the 
present data indicate that a distinct population of cells in 
the VMN, MPA and ARC coexpress steroid receptors (ER 
and PR) and two members of the p160 family of nuclear 
receptor coactivators (SRC-1 and SRC-2). A smaller pop-
ulation of E-induced PR cells in these three brain regions 
expressed only SRC-1, while less expressed only SRC-2. 
Finally, there was a small proportion of E-induced PR 
cells that expressed neither SRC-1 nor SRC-2. While it is 
possible that very low levels of SRC-1 and SRC-2 were not 
detected in PR cells by the immunofluorescent technique, 
it may be that ER and PR transcriptional activity in these 
cells is mediated by other coactivators in brain  [46] . In 
future experiments it will be important to investigate 
other coregulatory proteins that interact with ER and PR, 
including SRC-3 and silencing mediator of retinoic acid 
and thyroid hormone receptor (SMRT) which have re-
cently been shown to function together to coactivate ER 
transactivation of the PR gene in MCF-7 cells  [82] . It is 
also possible that the ER and PR in some cells function 
through a coactivator-independent pathway  [83, 84] . It 
should be noted that not all coactivator-containing cells 
expressed PR, suggesting that these coactivators function 
with other steroid receptors such as glucocorticoid and 
androgen receptors  [46] .
 There is evidence that SRC-1 and SRC-2 expression in 
rat brain is altered by steroids  [60, 80, 85–88] and endo-
crine disruptors  [89] , while other studies have found no 
effects of steroids on coactivator expression [see  46 for a 
more thorough review; 48, 49 ]. However, very little is 
known about hormonal regulation of coactivators in 
mouse brain. Therefore, the present study addressed the 
possibility of E regulation of SRC-1 or SRC-2 expression 
in mouse brain. EB treatment increased SRC-1 expression 
in the ARC compared with vehicle-treated control ani-
mals. In contrast, EB did not alter SRC-1 levels in the 
VMN or MPA, or SRC-2 expression in any of the three 
brain regions. It is possible that the present immunofluo-
rescent technique was not sensitive enough to detect 
slight changes in SRC-1 or SRC-2 expression in these oth-
er brain regions. The present E-induced increase of SRC-
1 in the ARC is consistent with other studies in rats that 
have found changes in SRC-1 protein over the estrous cy-
cle  [85] and E-induced increases in SRC-1 mRNA in the 
hypothalamus  [86] . The present findings suggest that E 
regulates SRC-1, but not SRC-2, in a brain-region-specif-
ic manner. 
 The mechanisms by which individual cells modulate 
steroid responsiveness in a given brain region is a funda-
mental issue in steroid hormone action in brain. Taken 
together with previous findings, the present results iden-
tify putative sites of functional interaction of ovarian ste-
roid receptors (ER  and PR) with nuclear receptor co-
activators (SRC-1 and SRC-2) in reproductively relevant 
brain regions. These results support and extend our pre-
vious findings that the majority of E-induced PR cells in 
the rat hypothalamus express SRC-1 and CBP  [48] and 
support the findings that SRC-1 and SRC-2 function in 
the hypothalamus to modulate hormone-dependent fe-
male sexual behavior  [54, 61, 64] . In addition, these re-
sults provide neuroanatomical support for the concept 
that these coactivators are important in ER transactiva-
tion of the PR gene in brain  [54, 61] . However, the func-
tional differences of these coactivators in ER-mediated 
activation of the PR gene in brain are not known. For ex-
ample, it is not known if these two coactivators contribute 
differentially to the ER-mediated induction of the two PR 
isoforms. In support of this idea, ER and other steroid 
receptors have distinct affinities for nuclear receptor co-
activators. For example, SRC-1 and SRC-2 from the rat 
hypothalamus and hippocampus physically associate 
with ER and PR in a receptor subtype- and brain region-
specific manner  [58, 65] . Interestingly, SRC-1 from the 
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hypothalamus interacts more with ER  than ER  , while 
SRC-2 associates with ER  but shows virtually no inter-
action with ER   [58, 65] . In addition, receptor-coactiva-
tor interactions are influenced by different ligands and 
response elements on DNA  [90–93] . In MCS80 Schwann 
cells, glucocorticoid receptors recruit SRC-1 or SRC-3, 
but not SRC-2, in the transactivation of a minimal gluco-
corticoid-sensitive reporter gene containing two GREs 
 [94, 95] . Studies in T47D cells reveal that SRC-1 preferen-
tially recruits CBP resulting in acetylation of histone H4, 
while SRC-2 recruits pCAF leading to acetylation of his-
tone H3  [96] . It has been suggested that this recruitment 
of differential histone acetyltransferases can modulate 
the transcription of various steroid-responsive genes. 
Moreover, ER (as well as androgen receptors) in the pres-
ence of classical hormone response elements, recruit dis-
tinct heterodimers of the SRC family members  [97] . In-
terestingly, on non-hormone response element-contain-
ing genes (such as AP-1 sites of early genes), ER recruit 
SRC proteins as monomers. Taken together, the present 
findings that many E-induced PR cells coexpress both 
SRC-1 and SRC-2 provide neuroanatomical support for 
the concept that steroid responsiveness can be fine-tuned 
not only by the presence or absence of coactivators but 
also by the ratio of these coactivators present within in-
dividual neurons. Thus, these distinct populations of 
cells expressing SRC-1 and SRC-2 may allow alternate ste-
roid receptor signaling pathways in the regulation of
behavior. Furthermore, the E-induced upregulation of 
SRC-1 expression in a brain-region-specific manner pro-
vides another mechanism by which E can increase the 
sensitivity of individual cells to steroids. Thus, studying 
the order and timing of recruitment of different coregula-
tor complexes to the promoter, which is likely to be cell- 
and region-specific, will be critical to understanding hor-
mone action in the brain.
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